Istradefylline 20 mg or 40 mg	Placebo	Daily OFF time	580	797	The change in daily OFF time was significantly reduced in the istradefylline 20 mg/day (−0.99 hours, P = .003) and istradefylline 40 mg/day (−0.96 hours, P = .003) groups compared with the placebo group (−0.23 hours).
Istradefylline 20 mg or 40 mg	Placebo	Secondary efficacy variables	9166	9251	No differences were observed among the groups for other secondary efficacy variables.
Istradefylline 20 mg	Istradefylline 40 mg	Daily ON time with problematic dyskinesia	8302	8416	Neither istradefylline 20 mg/day nor istradefylline 40 mg/day increased daily ON time with troublesome dyskinesia.
Istradefylline 20 mg	Istradefylline 40 mg	Daily OFF time	573	797	ResultsThe change in daily OFF time was significantly reduced in the istradefylline 20 mg/day (−0.99 hours, P = .003) and istradefylline 40 mg/day (−0.96 hours, P = .003) groups compared with the placebo group (−0.23 hours).
Istradefylline 20 mg	Istradefylline 40 mg	Daily OFF time	7750	8053	The changes from baseline at the end point for daily OFF time for placebo, istradefylline 20 mg/day, and istradefylline 40 mg/day were −0.23, −0.99 (P = .003), and −0.96 (P = .003) hours, respectively. The differences from the placebo were significant, but there were no difference between the 2 groups.
